Environmentally friendly chemistry important for manufacturing pharmaceuticals

November 08, 2012

Limiting the quantity of catalysts - substances that trigger a chemical reaction - used in the manufacture of pharmaceuticals is important, and research from the University of Gothenburg, Sweden, has now demonstrated that small quantities of copper work well in this respect.

"This is an important finding, not just academically but also for industry," says chemist Per-Fredrik Larsson.

Catalysis is an incredibly valuable tool in the field of chemistry, with the Haber-Bosch process being one of the most important catalytic processes in the world. It is used to manufacture fertilizer, and calculations show that without it the world's population would be just half of what it is today.

Precious metals are often used as catalysts in organic chemistry as they enable the production of many organic molecules with applications in areas such as pharmaceuticals and fine chemicals. As recently as 2010 Richard F. Heck, Ei-ichi Negishi and Akira Suzuki were awarded the Nobel Prize in Chemistry for their work on palladium catalysis.

"A problem with precious metals like palladium is that they are both expensive and harmful to the environment," says Per-Fredrik Larsson at the Department of Chemistry and Molecular Biology.

Recent years have seen researchers evaluating several different non-precious metals - primarily iron and copper - as cheap and environmentally friendly alternatives to precious metals.

"Iron catalysts have proven to be a competitive alternative to precious metals for a number of reactions," says Per-Fredrik Larsson. "An in-depth understanding of how these reactions work is incredibly important if we are to take this further. The results from our studies with iron led to several important insights into just how complex the chemistry can be."

Larsson's research group works not only with experimental methods but also with calculation models to understand how the chemistry works.

The trend for swapping precious metals for non-precious alternatives also has a flipside. It was discovered during experiments with iron catalysis in conjunction with professor Carsten Bolm of RWTH Aachen University in Germany that some reactions thought to be catalysed by iron had actually been catalysed by traces of copper in the commercially available iron source.

The fact that traces of copper could catalyse a number of different reactions was surprising as copper had previously been thought to be an ineffective catalyst requiring large quantities and high reaction temperatures.

"Our results show that copper has been given an undeservedly bad name as a catalyst," says Per-Fredrik Larsson. "Given that copper chemistry is over a century old, it's surprising that nobody's realised this before."

It is important in the pharmaceutical industry to limit the use of catalysts as the quantity of metal in the end-product is strictly regulated and the recovery process can be both difficult and expensive. As such, the finding that small quantities of copper can be used is an important discovery.

"We've developed and studied reactions with small quantities of copper and tried to understand how and why they work," says Per-Fredrik Larsson.

The results and conclusions for iron and copper catalysts are a major contribution to this field of research and are important for its continued development.
-end-
Contact:

Per-Fredrik Larsson, Department of Chemistry and Molecular Biology,
tel: +46 (0)31 786 9104
or +46 (0)701 432640,
e-mail: per-fredrik.larsson@chem.gu.se

University of Gothenburg

Related Pharmaceuticals Articles from Brightsurf:

A plot twist in pharmaceuticals: Single nanoparticles could pave the way for medicines on demand
For the first time, a single, twisted nanoparticle has been accurately measured and characterised in a lab, taking scientists one vital step closer to a time when medicines will be produced and blended on a microscopic scale.

New pharmaceuticals: public research combines efficiency with contained costs
Is the basic research that goes into the development of new drugs more efficiently conducted by public-sector scientists, pharmaceutical firms, or independent private laboratories?

New STM technique points way to new and purer pharmaceuticals
A research project led by chemists at the University of Warwick first used ultrahigh resolution scanning tunnelling microscopy to see the exact location of atoms and bonds within a molecule, and then employed these incredibly precise images to determine the interactions that bond molecules to one another.

Study describes cocktail of pharmaceuticals in waters in Bangladesh
An analysis revealed that water samples held a cocktail of pharmaceuticals and other compounds, including antibiotics, antifungals, anticonvulsants, anesthetics, antihypertensive drugs, pesticides, flame retardants and more.

Treating wastewater with ozone could convert pharmaceuticals into toxic compounds
With water scarcity intensifying, wastewater treatment and reuse are gaining popularity.

Study calls for improved sanitation and the environmental management of pharmaceuticals
Failure to ensure the environmental sustainability of growing patient access to medicines in developing economies could increase the risk of adverse environmental impacts, according to new research led by the University of Plymouth.

Chemicals for pharmaceuticals could be made cheaper and greener by new catalysts
High value chemicals used to make pharmaceuticals could be made much cheaper and quicker thanks to a series of new catalysts made by scientists at the University of Warwick in collaboration with GoldenKeys High-Tech Co., Ltd. in China.

Soaking up pharmaceuticals and personal care products from water
Medications excreted in the urine or dumped into the toilet can end up in the water supply, just like lotions or cosmetics that wash off the body and go down the sink or shower drain.

New study finds river wildlife contain cocaine, pharmaceuticals and pesticides
For the first time, researchers at King's College London, in collaboration with the University of Suffolk, have found a diverse array of chemicals, including illicit drugs and pesticides in UK river wildlife.

Metal-free catalyst to convert aldehyde into ketone, a basic structure of pharmaceuticals
We succeeded in synthesizing a ketone, a basic structure of many pharmaceuticals, from an aldehyde and a carboxylic acid using N-heterocyclic carbene catalyst under mild conditions.

Read More: Pharmaceuticals News and Pharmaceuticals Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.